<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28448514</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>4</Issue><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.</ArticleTitle><Pagination><MedlinePgn>e0175638</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0175638</ELocationID><Abstract><AbstractText>Pilocytic astrocytoma (PA) is the most common pediatric brain tumor. A recurrent feature of PA is deregulation of the mitogen activated protein kinase (MAPK) pathway most often through KIAA1549-BRAF fusion, but also by other BRAF- or RAF1-gene fusions and point mutations (e.g. BRAFV600E). These features may serve as diagnostic and prognostic markers, and also facilitate development of targeted therapy. The aims of this study were to characterize the genetic alterations underlying the development of PA in six tumor cases, and evaluate methods for fusion oncogene detection. Using a combined analysis of RNA sequencing and copy number variation data we identified a new BRAF fusion involving the 5' gene fusion partner GTF2I (7q11.23), not previously described in PA. The new GTF2I-BRAF 19-10 fusion was found in one case, while the other five cases harbored the frequent KIAA1549-BRAF 16-9 fusion gene. Similar to other BRAF fusions, the GTF2I-BRAF fusion retains an intact BRAF kinase domain while the inhibitory N-terminal domain is lost. Functional studies on GTF2I-BRAF showed elevated MAPK pathway activation compared to BRAFWT. Comparing fusion detection methods, we found Fluorescence in situ hybridization with BRAF break apart probe as the most sensitive method for detection of different BRAF rearrangements (GTF2I-BRAF and KIAA1549-BRAF). Our finding of a new BRAF fusion in PA further emphasis the important role of B-Raf in tumorigenesis of these tumor types. Moreover, the consistency and growing list of BRAF/RAF gene fusions suggests these rearrangements to be informative tumor markers in molecular diagnostics, which could guide future treatment strategies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tomić</LastName><ForeName>Tajana Tešan</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Department of Clinical Genetics, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olausson</LastName><ForeName>Josefin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Genetics, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilzén</LastName><ForeName>Annica</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Genetics, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabel</LastName><ForeName>Magnus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Children´s Cancer Centre, The Queen Silvia Children's Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Truvé</LastName><ForeName>Katarina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Bioinformatics core facility, Sahlgrenska academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sjögren</LastName><ForeName>Helene</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dósa</LastName><ForeName>Sándor</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tisell</LastName><ForeName>Magnus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Sahlgrenska University hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lannering</LastName><ForeName>Birgitta</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Bioinformatics core facility, Sahlgrenska academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Enlund</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Clinical chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinsson</LastName><ForeName>Tommy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Clinical Genetics, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Åman</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Sahlgrenska Cancer Center, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abel</LastName><ForeName>Frida</ForeName><Initials>F</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-6958-4487</Identifier><AffiliationInfo><Affiliation>Department of Clinical Genetics, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>04</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C104259">GTF2I protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019473">Transcription Factors, TFII</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D048493">Proto-Oncogene Proteins B-raf</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber><NameOfSubstance UI="D020928">Mitogen-Activated Protein Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>PLoS One. 2017 Sep 7;12 (9):e0184715</RefSource><PMID Version="1">28880959</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001254" MajorTopicYN="N">Astrocytoma</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056915" MajorTopicYN="N">DNA Copy Number Variations</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005091" MajorTopicYN="N">Exons</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020928" MajorTopicYN="N">Mitogen-Activated Protein Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050596" MajorTopicYN="Y">Oncogene Fusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048493" MajorTopicYN="N">Proto-Oncogene Proteins B-raf</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019473" MajorTopicYN="N">Transcription Factors, TFII</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>07</Month><Day>07</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>03</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28448514</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0175638</ArticleId><ArticleId IdType="pii">PONE-D-16-27149</ArticleId><ArticleId IdType="pmc">PMC5407815</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cell Mol Life Sci. 2012 Jun;69(11):1799-811</Citation><ArticleIdList><ArticleId IdType="pubmed">22159586</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Genet. 2013 Aug;45(8):927-32</Citation><ArticleIdList><ArticleId IdType="pubmed">23817572</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Cancer. 2016 Feb 15;138(4):881-90</Citation><ArticleIdList><ArticleId IdType="pubmed">26314551</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Bioinformatics. 2013;14 Suppl 7:S2</Citation><ArticleIdList><ArticleId IdType="pubmed">23815381</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):5957-62</Citation><ArticleIdList><ArticleId IdType="pubmed">23533272</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell. 2006 Oct 20;24(2):301-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17052463</ArticleId></ArticleIdList></Reference><Reference><Citation>Genome Res. 2002 Apr;12(4):656-64</Citation><ArticleIdList><ArticleId IdType="pubmed">11932250</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Neuropathol. 2010 Aug;120(2):271-3</Citation><ArticleIdList><ArticleId IdType="pubmed">20454969</ArticleId></ArticleIdList></Reference><Reference><Citation>Case Rep Med. 2012;2012:418672</Citation><ArticleIdList><ArticleId IdType="pubmed">22548077</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Dev Pathol. 2008 Mar-Apr;11(2):108-17</Citation><ArticleIdList><ArticleId IdType="pubmed">17990938</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2002 Jun 27;417(6892):949-54</Citation><ArticleIdList><ArticleId IdType="pubmed">12068308</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuropathol Exp Neurol. 2012 Jan;71(1):66-72</Citation><ArticleIdList><ArticleId IdType="pubmed">22157620</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Chromosomes Cancer. 2013 Mar;52(3):330-1</Citation><ArticleIdList><ArticleId IdType="pubmed">23225380</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuro Oncol. 2014 Oct;16(10):1408-16</Citation><ArticleIdList><ArticleId IdType="pubmed">24803676</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosurg. 2014 Dec;121(6):1474-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25259568</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosurg. 2003 Jun;98(6):1170-4</Citation><ArticleIdList><ArticleId IdType="pubmed">12816259</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Pathol. 2009 Jul;19(3):449-58</Citation><ArticleIdList><ArticleId IdType="pubmed">19016743</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Haematol. 2015 Mar;168(6):904-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25284716</ArticleId></ArticleIdList></Reference><Reference><Citation>Brief Bioinform. 2013 Jul;14(4):506-19</Citation><ArticleIdList><ArticleId IdType="pubmed">22877769</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncogene. 2009 May 21;28(20):2119-23</Citation><ArticleIdList><ArticleId IdType="pubmed">19363522</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2716-36</Citation><ArticleIdList><ArticleId IdType="pubmed">25192704</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2010 Mar 18;464(7287):427-30</Citation><ArticleIdList><ArticleId IdType="pubmed">20179705</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2016 Mar 18;44(5):e47</Citation><ArticleIdList><ArticleId IdType="pubmed">26582927</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Diagn. 2011 Nov;13(6):669-77</Citation><ArticleIdList><ArticleId IdType="pubmed">21884820</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Neuropathol. 2007 Aug;114(2):97-109</Citation><ArticleIdList><ArticleId IdType="pubmed">17618441</ArticleId></ArticleIdList></Reference><Reference><Citation>Small GTPases. 2015 ;6(3):135-44</Citation><ArticleIdList><ArticleId IdType="pubmed">26317377</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Cancer. 2009 Aug 18;101(4):722-33</Citation><ArticleIdList><ArticleId IdType="pubmed">19603027</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cancer Res Ther. 2010 Apr-Jun;6(2):221-3</Citation><ArticleIdList><ArticleId IdType="pubmed">20622373</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Dev. 2012 Dec 1;26(23):2561-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23152448</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene. 2012 Jan 15;492(1):32-41</Citation><ArticleIdList><ArticleId IdType="pubmed">22037610</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Neuropathol. 2011 Mar;121(3):397-405</Citation><ArticleIdList><ArticleId IdType="pubmed">21274720</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Paediatr. 2009 Oct;98(10):1620-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19594464</ArticleId></ArticleIdList></Reference><Reference><Citation>Genes Cancer. 2015 Jan;6(1-2):9-18</Citation><ArticleIdList><ArticleId IdType="pubmed">25821557</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Pathol. 2015 Mar;25(2):182-92</Citation><ArticleIdList><ArticleId IdType="pubmed">25040262</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pathol. 2009 Jun;218(2):172-81</Citation><ArticleIdList><ArticleId IdType="pubmed">19373855</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuro Oncol. 2011 Feb;13(2):223-34</Citation><ArticleIdList><ArticleId IdType="pubmed">21177781</ArticleId></ArticleIdList></Reference><Reference><Citation>Biol Cell. 2001 Sep;93(1-2):53-62</Citation><ArticleIdList><ArticleId IdType="pubmed">11730323</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neuropathol Exp Neurol. 2015 Jul;74(7):743-54</Citation><ArticleIdList><ArticleId IdType="pubmed">26083571</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Neuropathol. 2011 Jun;121(6):763-74</Citation><ArticleIdList><ArticleId IdType="pubmed">21424530</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancer Res. 2008 Nov 1;68(21):8673-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18974108</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Oncol. 2015 Mar 03;5:54</Citation><ArticleIdList><ArticleId IdType="pubmed">25785246</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>

